regorafenib monohydrate

A monohydrate salt of Regorafenib, a multikinase inhibitor used in the treatment of metastatic colorectal cancer and advanced gastrointestinal stromal tumors. Shows anti-angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition.Reference standards of Regorafenib Monohydrate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Regorafenib Monohydrate - API Standards
    [catalogue_number] => PA 18 35000
    [category_ids] => ,80,71,76,75,78,70,82,89,
    [chemical_name] => 
    [weight] => 500.83
    [form] => C21H17ClF4N4O4
    [cas] => 1019206-88-2
    [pslug] => 1019206-88-2-regorafenib-monohydrate-api-standards-pa1835000
    [latest_product] => 0
    [linkproducts] => 1
    [offers_id] => 8
    [offers_name] => Ready Stock
    [offers_status] => 1
    [offers_start_date] => 2024-12-16
    [offers_end_date] => 2024-12-31
    [pageview] => 2
    [offers_slug] => ready-stock
    [offers_product_id] => 42375
    [offers_product_code] => PA 18 35000
    [offers_master_id] => 8
    [offer_percentage] => 20 % OFF
    [offers_product_main_cat] => Pharmaceutical Reference Standards
)